Contributor since: 2010
Latest Articles
With Recent Trial Results, Furiex Pharmaceuticals Still Has Significant Upside Potential
Protalix: Undervalued Growth, Plus A Possible Biotech Breakthrough
Last Chance For A Bargain On Isis Pharmaceuticals?
Trius Therapeutics: Outstanding Potential, Discount Price
Derma Sciences: Growing Business, Blockbuster Pipeline
Pfizer Guidance Suggests Tremendous Potential for Pain Therapeutics
Nanosphere's Extraordinary Growth Potential in Medical Diagnostics
Building a Biotech Portfolio With High Potential Returns, Modest Risk
Tellabs: Cheap Like Cisco, But With Better Downside Protection
Careful Analysis Reveals Good Probability of Large Gains for Vical
Depomed: Light-Risk Small Pharma With Huge Potential
Pain Therapeutics: Optimistic Indicators, Large Upside Potential
Misunderstood News Offers Opportunity for Deep Discount on Momenta Pharmaceuticals
Myriad Genetics: Growing Medical Diagnostics Franchise at Value Price
Telecommunications Systems: Calling Another 'Stunningly Cheap' Stock
Neutral Tandem's 'Growth at a Discount' Story Remains Intact
Imperial Sugar: Buy for Value, Hold for Growth
QLT's Attractive Risk / Reward Profile